Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include haematology, haemostasis, and urinalysis analyzers. It conducts research and development at its facilities in Japan, France, New Zealand, Germany and the US. The company operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa, and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Sysmex Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Sysmex Corp Company Overview
- Sysmex Corp Company Snapshot
- Sysmex Corp Pipeline Products and Ongoing Clinical Trials Overview
- Sysmex Corp - Pipeline Analysis Overview
- Business Description
- Sysmex Corp - Key Facts
- Sysmex Corp - Major Products and Services
- Sysmex Corp Pipeline Products by Development Stage
- Sysmex Corp Pipeline Products Overview
- Antigen Saliva Test - COVID-19
- Antigen Saliva Test - COVID-19 Product Overview
- Antigen Test - COVID-19
- Antigen Test - COVID-19 Product Overview
- Automated Hematology Analyzer XN-31
- Automated Hematology Analyzer XN-31 Product Overview
- Blood-based Diagnostic Assay - Cancer
- Blood-based Diagnostic Assay - Cancer Product Overview
- Cancer Diagnostic Reagent
- Cancer Diagnostic Reagent Product Overview
- Cancer Related Gene Panel Test System
- Cancer Related Gene Panel Test System Product Overview
- Captiver System
- Captiver System Product Overview
- Companion Diagnostic DNA Test
- Companion Diagnostic DNA Test Product Overview
- Diagnostic Assay - Colorectal Cancer
- Diagnostic Assay - Colorectal Cancer Product Overview
- Diagnostic Test - Atopic Dermatitis
- Diagnostic Test - Atopic Dermatitis Product Overview
- Diagnostic Test - Liver Fibrosis
- Diagnostic Test - Liver Fibrosis Product Overview
- Diagnostic Test - Pancreatic Cancer
- Diagnostic Test - Pancreatic Cancer Product Overview
- Immuno-flowFISH - Bone Marrow Cancer
- Immuno-flowFISH - Bone Marrow Cancer Product Overview
- Immuno-flowFISH Test - Leukaemia
- Immuno-flowFISH Test - Leukaemia Product Overview
- Immunochemistry Test - Bile Duct Cancer
- Immunochemistry Test - Bile Duct Cancer Product Overview
- Immunochemistry Test - CK19F
- Immunochemistry Test - CK19F Product Overview
- Immunochemistry Test - FSH
- Immunochemistry Test - FSH Product Overview
- Immunochemistry Test - HAV Ab
- Immunochemistry Test - HAV Ab Product Overview
- Immunochemistry Test - HBc IgM
- Immunochemistry Test - HBc IgM Product Overview
- Immunochemistry Test - LH
- Immunochemistry Test - LH Product Overview
- Immunochemistry Test - Tg Ab
- Immunochemistry Test - Tg Ab Product Overview
- Immunochemistry Test - TPO Ab
- Immunochemistry Test - TPO Ab Product Overview
- Immunochemistry Test - TR Ab
- Immunochemistry Test - TR Ab Product Overview
- Inherited Retinal Dystrophy Gene Panel Test System
- Inherited Retinal Dystrophy Gene Panel Test System Product Overview
- Liquid Biopsy System
- Liquid Biopsy System Product Overview
- Minimally Invasive Postprandial Hyperglycemia Monitoring System
- Minimally Invasive Postprandial Hyperglycemia Monitoring System Product Overview
- Multiplex Gene Panel Test
- Multiplex Gene Panel Test Product Overview
- Next Generation Sequencing Based Companion Diagnostic Assay
- Next Generation Sequencing Based Companion Diagnostic Assay Product Overview
- Next-Generation Diagnostic Reagent - Dementia
- Next-Generation Diagnostic Reagent - Dementia Product Overview
- NGS Analysis Software
- NGS Analysis Software Product Overview
- Non-Invasive Prenatal Test - Down's Syndrome
- Non-Invasive Prenatal Test - Down's Syndrome Product Overview
- OGT SLE Test
- OGT SLE Test Product Overview
- OncoBEAM - Hepatocellular Carcinoma
- OncoBEAM - Hepatocellular Carcinoma Product Overview
- OncoBEAM - Pancreatic Cancer
- OncoBEAM - Pancreatic Cancer Product Overview
- PA-100 Analyser With PA AST Panel U-0501
- PA-100 Analyser With PA AST Panel U-0501 Product Overview
- Protein Biomarker Assay - Prostate Cancer
- Protein Biomarker Assay - Prostate Cancer Product Overview
- Screening System - Cervical Cancer
- Screening System - Cervical Cancer Product Overview
- Sysmex XQ-320 Automated Hematology Analyzer
- Sysmex XQ-320 Automated Hematology Analyzer Product Overview
- Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay
- Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay Product Overview
- Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay
- Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay Product Overview
- Sysmex Corp - Key Competitors
- Sysmex Corp - Key Employees
- Sysmex Corp - Key Employee Biographies
- Sysmex Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Sysmex Corp, Recent Developments
- Apr 18, 2023: Juntendo University, Sysmex, and ThinkCyte collaborate to advance the early detection and treatment of blood cancer
- Apr 17, 2023: Sysmex to establish new manufacturing base in India
- Apr 13, 2023: Sysmex Inostics and Genomic Testing Cooperative form partnership to accelerate therapeutic discovery and development
- Feb 14, 2023: Sysmex Inostics opens Cancer Research Excellence Program for submissions
- Feb 09, 2023: Sysmex Announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2023
- Feb 08, 2023: Sysmex Corp. Notice of Changes in Representative Directors
- Sep 08, 2022: Toho pharmaceutical and Sysmex to Commence dry ice-free supply of quality control reagents for clinical chemistry tests
- Jul 01, 2022: Sysmex launches sample transportation system modules for XR Series of Automated Hematology Analyzer
- Feb 10, 2022: Sysmex announces Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2022
- Nov 10, 2021: Sysmex Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2021, and Revision of Full-Year Financial Forecasts
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Sysmex Corp Pipeline Products and Ongoing Clinical Trials Overview
- Sysmex Corp Pipeline Products by Equipment Type
- Sysmex Corp Pipeline Products by Indication
- Sysmex Corp, Key Facts
- Sysmex Corp, Major Products and Services
- Sysmex Corp Number of Pipeline Products by Development Stage
- Sysmex Corp Pipeline Products Summary by Development Stage
- Antigen Saliva Test - COVID-19 - Product Status
- Antigen Saliva Test - COVID-19 - Product Description
- Antigen Test - COVID-19 - Product Status
- Antigen Test - COVID-19 - Product Description
- Automated Hematology Analyzer XN-31 - Product Status
- Automated Hematology Analyzer XN-31 - Product Description
- Blood-based Diagnostic Assay - Cancer - Product Status
- Blood-based Diagnostic Assay - Cancer - Product Description
- Cancer Diagnostic Reagent - Product Status
- Cancer Diagnostic Reagent - Product Description
- Cancer Related Gene Panel Test System - Product Status
- Cancer Related Gene Panel Test System - Product Description
- Captiver System - Product Status
- Captiver System - Product Description
- Companion Diagnostic DNA Test - Product Status
- Companion Diagnostic DNA Test - Product Description
- Diagnostic Assay - Colorectal Cancer - Product Status
- Diagnostic Assay - Colorectal Cancer - Product Description
- Diagnostic Test - Atopic Dermatitis - Product Status
- Diagnostic Test - Atopic Dermatitis - Product Description
- Diagnostic Test - Liver Fibrosis - Product Status
- Diagnostic Test - Liver Fibrosis - Product Description
- Diagnostic Test - Pancreatic Cancer - Product Status
- Diagnostic Test - Pancreatic Cancer - Product Description
- Immuno-flowFISH - Bone Marrow Cancer - Product Status
- Immuno-flowFISH - Bone Marrow Cancer - Product Description
- Immuno-flowFISH Test - Leukaemia - Product Status
- Immuno-flowFISH Test - Leukaemia - Product Description
- Immunochemistry Test - Bile Duct Cancer - Product Status
- Immunochemistry Test - Bile Duct Cancer - Product Description
- Immunochemistry Test - CK19F - Product Status
- Immunochemistry Test - CK19F - Product Description
- Immunochemistry Test - FSH - Product Status
- Immunochemistry Test - FSH - Product Description
- Immunochemistry Test - HAV Ab - Product Status
- Immunochemistry Test - HAV Ab - Product Description
- Immunochemistry Test - HBc IgM - Product Status
- Immunochemistry Test - HBc IgM - Product Description
- Immunochemistry Test - LH - Product Status
- Immunochemistry Test - LH - Product Description
- Immunochemistry Test - Tg Ab - Product Status
- Immunochemistry Test - Tg Ab - Product Description
- Immunochemistry Test - TPO Ab - Product Status
- Immunochemistry Test - TPO Ab - Product Description
- Immunochemistry Test - TR Ab - Product Status
- Immunochemistry Test - TR Ab - Product Description
- Inherited Retinal Dystrophy Gene Panel Test System - Product Status
- Inherited Retinal Dystrophy Gene Panel Test System - Product Description
- Liquid Biopsy System - Product Status
- Liquid Biopsy System - Product Description
- Minimally Invasive Postprandial Hyperglycemia Monitoring System - Product Status
- Minimally Invasive Postprandial Hyperglycemia Monitoring System - Product Description
- Multiplex Gene Panel Test - Product Status
- Multiplex Gene Panel Test - Product Description
- Next Generation Sequencing Based Companion Diagnostic Assay - Product Status
- Next Generation Sequencing Based Companion Diagnostic Assay - Product Description
- Next-Generation Diagnostic Reagent - Dementia - Product Status
- Next-Generation Diagnostic Reagent - Dementia - Product Description
- NGS Analysis Software - Product Status
- NGS Analysis Software - Product Description
- Non-Invasive Prenatal Test - Down's Syndrome - Product Status
- Non-Invasive Prenatal Test - Down's Syndrome - Product Description
- OGT SLE Test - Product Status
- OGT SLE Test - Product Description
- OncoBEAM - Hepatocellular Carcinoma - Product Status
- OncoBEAM - Hepatocellular Carcinoma - Product Description
- OncoBEAM - Pancreatic Cancer - Product Status
- OncoBEAM - Pancreatic Cancer - Product Description
- PA-100 Analyser With PA AST Panel U-0501 - Product Status
- PA-100 Analyser With PA AST Panel U-0501 - Product Description
- Protein Biomarker Assay - Prostate Cancer - Product Status
- Protein Biomarker Assay - Prostate Cancer - Product Description
- Screening System - Cervical Cancer - Product Status
- Screening System - Cervical Cancer - Product Description
- Sysmex XQ-320 Automated Hematology Analyzer - Product Status
- Sysmex XQ-320 Automated Hematology Analyzer - Product Description
- Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay - Product Status
- Sysmex XS-1000i AutoLoader Automated Hematology Analyzer - IG% Assay - Product Description
- Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay - Product Status
- Sysmex XS-1000i Automated Hematology Analyzer - IG% Assay - Product Description
- Sysmex Corp, Key Employees
- Sysmex Corp, Key Employee Biographies
- Sysmex Corp, Other Locations
- Sysmex Corp, Subsidiaries
- Sysmex Corp, Joint Venture
- Glossary
- Sysmex Corp Pipeline Products by Equipment Type
- Sysmex Corp Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alere Inc
- Bayer Healthcare LLC, Diabetes Care Division
- Beckman Coulter Inc
- Becton Dickinson and Co
- bioMerieux SA
- Bio-Rad Laboratories Inc
- Cytek Biosciences Inc
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Yagami Inc
